Informação sobre produto
- (?R)-?-[[(5S)-5-[3-Chloro-2-methyl-4-[2-(4-methyl-1-piperazinyl)ethoxy]phenyl]-6-(5-fluoro-2-furanyl)thieno[2,3-d]pyrimidin-4-yl]oxy ]-2-[[1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl]methoxy]benzenepropanoic acid
S 63845 is a novel anti-cancer drug that belongs to the class of ubiquitin ligases. It has been shown to induce apoptosis in cancer cells and inhibit tumor growth in vivo. S 63845 also inhibits the phosphorylation of cyclin D2, which may be a potential biomarker for sclerosing cholangitis (SCC). This compound is highly cytotoxic and has been found to be effective against subcutaneous tumors in mice. S 63845 also inhibits the proliferation of primary cells and has been shown to significantly reduce hepatic steatosis, as well as inhibiting inflammation caused by toll-like receptor 4 activation.
Propriedades químicas
Consulta técnica sobre: 3D-BS166833 S 63845
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
